BREAKING: Grizzly Affair — American tech company’s networking gear is powering Russian battlefield communications in Ukraine. The company is Ubiquiti, $UI, a $34 billion Wi-Fi giant whose founder became the youngest owner of an NBA Team in 2012.
Johnson & Johnson Was Caught Adding Cancer Causing Carcinogens Into Their Sunscreens.....
The EXACT SAME CANCER That The Company Makes The Majority Of Their Revenue Selling Drugs For....🤨😒😡
hiddeninplainsight1
Introducing #UniFiEnterprise: A new class of #UniFi technology built for the most demanding networks.
Phase 1: Enterprise Fortress Gateway
🔹 25G Networking
🔹 High Availability System Design
🔹 License-Free SSL Inspection
More: https://t.co/rUfusK38CD
6 Secrets of Ivermectin: The Medication That Keeps on Giving
It was recently revealed that vaccine pusher Chris Cuomo is taking ivermectin for "long COVID."
He admits, "Joe Rogan was right" and that the public was misled about ivermectin.
Ivermectin is not only an effective treatment for COVID and spike protein syndromes, but people who take this "miracle drug" will also enjoy these 6 benefits:
#1 - It inhibits flu and RSV viral replication, which is why it’s included in the FLCCC flu and RSV protocols.
#2 - It reduces inflammation throughout the body.
#3 - Improves the gastrointestinal microbiome by boosting levels of the probiotic Bifidobacterium.
#4 - It revolutionized veterinary medicine and arguably stabilized the world’s food supply.
#5 - May help with athletic and sports performance by boosting cellular energy output in the heart.
#6 - It has profound anti-cancer properties.
Best of all, Ivermectin is incredibly safe and cheap.
When you compare Molnupiravir and Ivermectin head-to-head in the context of COVID-19, you can see what a disgraceful, overpriced stink-bomb Molnupiravir actually is:
Ivermectin: 62% improvement, 99 studies, $1 per pill
Merck’s Show Pony: 15% improvement, 34 studies, $707 per pill
This information was gathered from an article written by @MDMichaelTurner (give him a follow).
Read the full in-depth article in the comment below: